Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Verdosome was a privately held U.S. clinical laboratory company based in Wheat Ridge, Colorado. The company appears to have combined consumer-oriented genetic testing with molecular diagnostic laboratory services, including personalized DNA reports related to cannabinoid response and a saliva-based SARS-CoV-2 testing product called COVID Pod. Publicly available materials describe Verdosome as a molecular testing laboratory rather than a drug developer, with no evidence of a therapeutic pipeline or clinical-stage biopharma programs. Corporate and registry records suggest the entity is no longer actively operating despite its historical NPI registration and prior commercialization activities.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Verdosome.